Pence names Adams Indiana’s health commissioner
Gov. Mike Pence has named Indianapolis anesthesiologist Dr. Jerome Adams to be commissioner of the Indiana State Department of Health.
Gov. Mike Pence has named Indianapolis anesthesiologist Dr. Jerome Adams to be commissioner of the Indiana State Department of Health.
Starting Jan. 1, Wal-Mart will no longer offer health insurance to employees who work less than an average of 30 hours a week. The move, which would affect 30,000 employees, follows similar decisions by Target, Home Depot and others.
The governor met with Health and Human Services Secretary Sylvia Burwell on Monday in Washington, D.C., but said no deal has been reached yet.
Medicare will reduce payments to 68 Indiana hospitals—a 62-percent increase from last year—for having too many patients return within 30 days.
Takeda Pharmaceutical Co. was ordered by a jury to pay more than $2 million to a woman who claimed the company’s Actos diabetes medicine caused her bladder cancer, in the latest of thousands of lawsuits involving the drug to go to trial.
Executives knew by 2004 that studies found links between Actos and cancer, and didn’t issue a warning until seven years later to protect billions of dollars in sales of the drug, attorney Michael Miller told a state-court jury in Philadelphia on Thursday.
The European Union's antitrust authority has approved the $5.4 billion sale of Novartis' animal health division to Indianapolis-based pharmaceutical firm Eli Lilly and Co.
Shelbyville’s Major will break ground on an $89 million hospital next month. Meanwhile, hospital systems around the state are talking about consolidating facilities or turning unused bed space to new uses.
Pence asked Obama for the meeting in a letter Thursday, suggesting it could occur while Obama is in southwestern Indiana on Friday to tour a steel processing company to mark Manufacturing Day.
Contract talks broke down Wednesday between Anthem Blue Cross and Blue Shield and a network of five hospitals and other facilities, leaving tens of thousands of patients facing higher health insurance costs.
Tabalumab was expected to generate about $250 million to $300 million a year in sales in several years.
Design can help thwart antibiotic-resistant bacteria
Health benefits are still demanded by the most-valued workers.
Gains are needed on top of significant streamlining already in place.
The clinics could rearrange the system by forcing price quotes and demanding that providers follow-through.
An Oklahoma federal judge dealt a blow to President Barack Obama’s health-care law, invalidating IRS rules aimed at making policies affordable for consumers around the country.
Indianapolis Business Journal gathered leaders in the state's health care and benefits sector for a Power Breakfast panel discussion Sept. 26. The panel discussed disruption of employer clinics, health care spending and more.
WellPoint created an HMO joint venture with seven big hospitals in Los Angeles. Could it do something similar here? Quite possibly.
Endocyte’s lead drug showed big impact on lung cancer patients, but some analysts think the company should scrap it for a newer drug that is more powerful.